Mesenchymal stem cell (MSC) research is central to regenerative medicine and advanced cell therapy. MSCs drive regeneration, immune modulation, and tissue repair across musculoskeletal, cardiovascular, neurological, and immune systems. Their broad therapeutic relevance positions MSC-based therapies at the forefront of advanced therapeutic medicinal products (ATMPs) and next-generation regenerative therapies.
MSCs demonstrate multipotent differentiation capacity, strong immunomodulatory properties, and potent paracrine signaling activity. Ongoing MSC research targets osteoarthritis, spine and cartilage defects, graft-versus-host disease, Crohn’s disease, myocardial infarction, stroke, liver cirrhosis, lung injury, and autoimmune disorders. As MSC manufacturing scales for clinical translation, reproducibility, consistency, and controlled expansion kinetics become critical quality attributes.
Transitioning from FBS-based media to chemically defined, xeno-free culture systems is essential to reduce heterogeneity and improve safety. Defined MSC culture media enhance regulatory alignment, support robust scale-up, and enable scalable MSC culture for translational research, preclinical studies, and clinical manufacturing. Reliable systems preserve MSC phenotype, ensure high cell yields, and facilitate workflow simplification in biomanufacturing environments.
CELLnTEC provides specialised MSC culture media optimized for efficient isolation and rapid expansion of bone marrow and adipose-derived MSCs. These precision media solutions enable high-performance MSC culture without plate coatings (no coating), reducing process complexity while maintaining consistency and reproducibility. Xeno-free, clinically upgradable formulations allow seamless transition from research-grade applications to GMP-compliant clinical manufacturing.
By offering chemically defined, xeno-free MSC media, CELLnTEC supports the development of standardized, scalable cell therapy platforms aligned with ATMP regulatory frameworks. Defined in vitro systems contribute to the 3R principle (Reduce, Refine, Replace) by minimizing reliance on animal-derived components, reducing experimental animal use, and enabling predictive human-relevant in vitro models. This approach accelerates therapeutic development while promoting ethical and scientifically advanced regenerative medicine.
Whether optimizing MSC isolation workflows, improving expansion kinetics, or advancing toward clinical translation, CELLnTEC’s precision media reduce variability and strengthen process control. Scalable, xeno-free formulations enhance MSC manufacturing performance and support the development of safe, reproducible MSC-based therapeutics for immune-mediated diseases and regenerative medicine applications.
Enables efficient MSC isolation directly from primary bone marrow and adipose tissue.
Ready-to-use format for streamlined routine MSC culture work.
Suitable for standard monolayers, spheroids and scaffold-based 3D constructs.
Universal base chemistry supporting stable, conditions that preserve MSC viability, growth and multipotency across all culture stages.
Adipose biology and metabolic disorder research with adipogenic MSC differentiation.
Cartilage and joint regeneration studies, including osteoarthritis and cartilage repair models.
Expansion of bone marrow–derived MSCs to support research in cell transplantation approaches for spinal cord injury regeneration.
Immunomodulation and immune–MSC interaction studies in vitro.
Expansion of adipose-derived MSCs for orthopaedic and metabolic disease models.
High-throughput screening of small molecules or biologics on MSC proliferation and differentiation.
1
Supports isolation and expansion without FBS for MSC expansion.
3
One-bottle, one-step preparation simplifies daily MSC culture routines.
2
Advanced MSC culture systems help replace or reduce animal models in preclinical work.
4
Rapid MSC proliferation is achieved in standard tissue culture plastic, eliminating extra coating steps.
Primary epithelial cells growing in CnT-NX-EX display a highly proliferative phenotype. For differentiation experiments, it is recommended to switch to the CnT-PR-D or CnT-PR-3D differentiation media.
